Jocelyn Côté

Jocelyn Côté

Auto-generated profile, based on publicly available information

Jocelyn Côté

Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Molecular Cell
Verified
Journal Article
Closed access
DCDonghang Cheng
Donghang Cheng
JCJocelyn Côté
Jocelyn Côté
SSSalam Shaaban
Salam Shaaban
MBMark T. Bedford
Mark T. Bedford

1 December 2003 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
Francois-Michel BoisvertFrancois-Michel Boisvert
Francois-Michel Boisvert
JCJocelyn Côté
Jocelyn Côté
MBMarie-Chloé Boulanger
Marie-Chloé Boulanger
SRStéphane Richard
Stéphane Richard
Arginine methylation is a post-translational modification that results in the formation of asymmetrical and symmetrical dimethylated arginines (a- and sDMA). This modification is catalyzed by type I and II protein-arginine methyltransferases (PRMT), respectively. The two major enzymes PRMT1 (type I) and PRMT5 (type II) preferentially methylate arginines located in RG-rich clusters. Arginine methylation is a common modification, but the reagents for detecting this modification have been lacking. Thus, fewer than 20 proteins have been identified in the last 40 years as containing dimethylated arginines. We have generated previously four arginine methyl-specific antibodies; ASYM24 and ASYM25 are specific for aDMA, whereas SYM10 and SYM11 recognize sDMA. All of these antibodies were generated by using peptides with aDMA or sDMA in the context of different RG-rich sequences. HeLa cell extracts were used to purify the protein complexes recognized by each of the four antibodies, and the proteins were identified by microcapillary reverse-phase liquid chromatography coupled on line with electrospray ionization tandem mass spectrometry. The analysis of two tandem mass spectra for each methyl-specific antibody resulted in the identification of over 200 new proteins that are putatively arginine-methylated. The major protein complexes that were purified include components required for pre-mRNA splicing, polyadenylation, transcription, signal transduction, and cytoskeleton and DNA repair. These findings provide a basis for the identification of the role of arginine methylation in many cellular processes.

1 December 2017 in Developmental Cell
Verified
Journal Article
Closed access
HGHuishan Guo
Huishan Guo
MCManeka Chitiprolu
Maneka Chitiprolu
LRLuc Roncevic
Luc Roncevic
CJCharlotte Javalet
Charlotte Javalet
FHFiona J. Hemming
Fiona J. Hemming
Derrick J. GibbingsDerrick J. Gibbings
Derrick J. Gibbings

1 August 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JCJocelyn Côté
Jocelyn Côté
SRStéphane Richard
Stéphane Richard
The Tudor domain is an ∼60-amino acid structure motif in search of a function. Herein we show that the Tudor domains of the spinal muscular atrophy gene product SMN, the splicing factor 30 kDa (SPF30), and the Tudor domain-containing 3 (TDRD3) proteins interacted with arginine-glycine-rich motifs in a methylarginine-dependent manner. The Tudor domains also associated with methylarginine-containing cellular proteins, providing evidence that methylated arginines represent physiological ligands for this protein module. In addition, we report that spliceosomal small nuclear ribonucleoprotein particles core Sm proteins accumulated in the cytoplasm when arginine methylation was inhibited with adenosine dialdehyde or in the presence of an excessive amount of unmethylated arginine-glycine-rich peptides. These data provide in vivo evidence in support of a role for arginine methylation in the proper assembly and localization of spliceosomal Sm proteins.

1 January 2003 in Molecular Biology of the Cell
Verified
Journal Article
Open access
JCJocelyn Côté
Jocelyn Côté
Francois-Michel BoisvertFrancois-Michel Boisvert
Francois-Michel Boisvert
MBMarie-Chloé Boulanger
Marie-Chloé Boulanger
MBMark Bedford
Mark Bedford
SRStéphane Richard
Stéphane Richard
RNA binding proteins often contain multiple arginine glycine repeats, a sequence that is frequently methylated by protein arginine methyltransferases. The role of this posttranslational modification in the life cycle of RNA binding proteins is not well understood. Herein, we report that Sam68, a heteronuclear ribonucleoprotein K homology domain containing RNA binding protein, associates with and is methylated in vivo by the protein arginineN-methyltransferase 1 (PRMT1). Sam68 contains asymmetrical dimethylarginines near its proline motif P3 as assessed by using a novel asymmetrical dimethylarginine-specific antibody and mass spectrometry. Deletion of the methylation sites and the use of methylase inhibitors resulted in Sam68 accumulation in the cytoplasm. Sam68 was also detected in the cytoplasm of PRMT1-deficient embryonic stem cells. Although the cellular function of Sam68 is unknown, it has been shown to export unspliced human immunodeficiency virus RNAs. Cells treated with methylase inhibitors prevented the ability of Sam68 to export unspliced human immunodeficiency virus RNAs. Other K homology domain RNA binding proteins, including SLM-1, SLM-2, QKI-5, GRP33, and heteronuclear ribonucleoprotein K were also methylated in vivo. These findings demonstrate that RNA binding proteins are in vivo substrates for PRMT1, and their methylation is essential for their proper localization and function.

1 November 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IGIsabelle Goulet
Isabelle Goulet
GGGabrielle Gauvin
Gabrielle Gauvin
SBSophie Boisvenue
Sophie Boisvenue
JCJocelyn Côté
Jocelyn Côté
PRMT1 is the predominant member of a family of protein arginine methyltransferases (PRMTs) that have been implicated in various cellular processes, including transcription, RNA processing, and signal transduction. It was previously reported that the human PRMT1 pre-mRNA was alternatively spliced to yield three isoforms with distinct N-terminal sequences. Close inspection of the genomic organization in the 5′-end of the PRMT1 gene revealed that it can produce up to seven protein isoforms, all varying in their N-terminal domain. A detailed biochemical characterization of these variants revealed that unique N-terminal sequences can influence catalytic activity as well as substrate specificity. In addition, our results uncovered the presence of a functional nuclear export sequence in PRMT1v2. Finally, we find that the relative balance of PRMT1 isoforms is altered in breast cancer.